NYSE:GRXGabelli Healthcare & WellnessRx Trust Closed-Ended Fund Stock Price, Forecast & News

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's stock was trading at $9.45 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, GRX stock has increased by 12.7% and is now trading at $10.65.
View which stocks have been most impacted by Coronavirus.

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund announced a quarterly dividend on Friday, May 15th. Stockholders of record on Tuesday, June 16th will be paid a dividend of $0.14 per share on Tuesday, June 23rd. This represents a $0.56 dividend on an annualized basis and a dividend yield of 5.26%. The ex-dividend date of this dividend is Monday, June 15th.
View Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's dividend history.

News headlines about GRX stock have been trending positive on Tuesday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund earned a media sentiment score of 2.8 on InfoTrie's scale. They also assigned news coverage about the investment management company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future.
View the latest news about Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund.

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 2,500 shares, an increase of 31.6% from the December 15th total of 1,900 shares. Based on an average daily trading volume, of 32,000 shares, the days-to-cover ratio is presently 0.1 days.
View Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's Short Interest.

Some companies that are related to Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund include 1ST TR SR FR 20/COM (FIV), Aberdeen Income Credit Strategies Fund (ACP), Aberdeen International (AABVF), Aberdeen Total Dynamic Dividend Fund (AOD), AllianceBernstein Natnl Muncpl Incm Fnd. (AFB), ALLIANZGI CNV &/COM (CBH), Allianzgi Convertible & Income Fund (NCV), Allianzgi Convertible & Income Fund II (NCZ), Allianzgi NFJ Dividend int & Prm Stgy Fd (NFJ), Alpine Global Dynamic Dividend Fund (AGD), Apollo Tactical Income Fund (AIF), Ares Dynamic Credit Allocation Fund (ARDC), BLACKROCK 2022/COM (BGIO), Blackrock Coporate High Yield Fund (HYT) and Blackrock Credit Allocation Income Trust (BTZ).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund investors own include Gabelli Equity Trust (GAB), Cisco Systems (CSCO), Park City Group (PCYG), AT&T (T), AbbVie (ABBV), Cohen & Steers Clsd-End Optuny Fnd (FOF), General Electric (GE), Gilead Sciences (GILD), Johnson & Johnson (JNJ) and KeyCorp (KEY).

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "GRX."

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Raymond James & Associates (0.00%), UBS Group AG (0.00%), Aviance Capital Partners LLC (0.00%), Blue Bell Private Wealth Management LLC (0.00%), Matisse Capital (0.00%) and Janney Montgomery Scott LLC (0.00%). Company insiders that own Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund stock include James P Conn, Mario J Gabelli and Salvatore J Zizza.
View institutional ownership trends for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund.

GRX stock was sold by a variety of institutional investors in the last quarter, including Janney Montgomery Scott LLC.
View insider buying and selling activity for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund.

GRX stock was acquired by a variety of institutional investors in the last quarter, including UBS Group AG, Blue Bell Private Wealth Management LLC, Aviance Capital Partners LLC, Matisse Capital, Raymond James & Associates, and Mid Atlantic Financial Management Inc. ADV.
View insider buying and selling activity for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund.

Shares of GRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of GRX stock can currently be purchased for approximately $10.65.

The official website for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund is www.gabelli.com.

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's mailing address is 1 Corporate Ctr, RYE, NY 10580-1485, United States. The investment management company can be reached via phone at 914-921-5000.